KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Dividends payables (2018 - 2025)

Astrana Health's Dividends payables history spans 7 years, with the latest figure at $638000.0 for Q4 2024.

  • For Q4 2024, Dividends payables changed 0.0% year-over-year to $638000.0; the TTM value through Dec 2024 reached $638000.0, changed 0.0%, while the annual FY2024 figure was $638000.0, 0.0% changed from the prior year.
  • Dividends payables for Q4 2024 was $638000.0 at Astrana Health, roughly flat from $638000.0 in the prior quarter.
  • Across five years, Dividends payables topped out at $664000.0 in Q4 2022 and bottomed at $337000.0 in Q1 2020.
  • The 5-year median for Dividends payables is $556000.0 (2021), against an average of $566450.0.
  • The largest annual shift saw Dividends payables skyrocketed 78.97% in 2020 before it decreased 3.92% in 2023.
  • A 5-year view of Dividends payables shows it stood at $485000.0 in 2020, then grew by 14.64% to $556000.0 in 2021, then rose by 19.42% to $664000.0 in 2022, then fell by 3.92% to $638000.0 in 2023, then changed by 0.0% to $638000.0 in 2024.
  • Per Business Quant, the three most recent readings for ASTH's Dividends payables are $638000.0 (Q4 2024), $638000.0 (Q3 2024), and $638000.0 (Q2 2024).